Analysis

Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report

Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health

What to expect when Altria (MO) reports first quarter 2024 earnings results

Shares of Altria Group, Inc. (NYSE: MO) stayed green on Wednesday. The stock has dropped 8% over the past one month. The

What to look for when Hasbro (HAS) reports first quarter 2024 earnings results

Shares of Hasbro Inc. (NASDAQ: HAS) stayed green on Tuesday. The stock has gained 8% year-to-date. The toymaker is scheduled to report its

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results

Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today. Total sales increased 2.2% year-over-year to $10 billion. Organic sales growth was 10.8%. Net earnings decreased 7% to $1.22

April 17, 2024

US Bancorp (USB) Q1 2024 Earnings: Key financials and quarterly highlights

US Bancorp (NYSE: USB) reported its first quarter 2024 earnings results today. Total net revenue decreased 6.4% year-over-year to $6.7 billion. Net income applicable to US Bancorp common shareholders decreased

April 17, 2024

UAL Earnings: United Airlines Q1 loss narrows on higher revenues; results beat

United Airlines Holdings, Inc. (NYSE: UAL) reported a narrower net loss for the first quarter of 2024, on an adjusted basis. The bottom line benefitted from an increase in revenues.

April 16, 2024

Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,

Viewing Highlight
Loading...
Highlight
Close
Top